| Nov 1 |
Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript
|
| Nov 1 |
Biodesix, Inc. (BDSX) Reports Q3 Loss, Misses Revenue Estimates
|
| Nov 1 |
Biodesix GAAP EPS of -$0.07 beats by $0.01, revenue of $18.2M misses by $0.32M
|
| Nov 1 |
Biodesix Announces Third Quarter 2024 Results and Highlights
|
| Oct 30 |
With 47% ownership, Biodesix, Inc. (NASDAQ:BDSX) insiders have a lot riding on the company's future
|
| Oct 29 |
Biodesix to Participate in Three Investor Conferences in November
|
| Oct 18 |
Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024
|
| Oct 7 |
Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study
|
| Sep 5 |
Biodesix to Present at Two Investor Conferences in September
|
| Aug 10 |
Biodesix Second Quarter 2024 Earnings: Beats Expectations
|
